Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 15.51% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Sterling Infrastructure
STRL
$16.9B
| $28.7M | 0.04% |
873,529
-33,243
| -4% | -$978K |
|
552
Prothena Corp
PRTA
$466M
| $28.6M | 0.04% |
474,900
-162,000
| -25% | -$9.49M |
|
553
Teradata
TDC
$2.57B
| $28.5M | 0.04% |
847,800
+246,700
| +41% | +$7.94M |
|
554
Goodyear
GT
$1.78B
| $28.5M | 0.04% |
2,809,754
+1,733,700
| +161% | +$18.9M |
|
555
Tower Semiconductor
TSEM
$28.6B
| $28.5M | 0.04% |
659,646
+479,686
| +267% | +$20.8M |
|
|
PAMT
556
PAMT Corp
PAMT
$285M
| $28.3M | 0.04% |
1,094,208
-76,326
| -7% | -$2.18M |
|
557
Philips
PHG
$26.8B
| $28.2M | 0.04% |
2,196,933
+1,483,052
| +208% | +$17.9M |
|
|
EDR
558
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $28.1M | 0.04% |
1,246,900
-211,100
| -14% | -$4.5M |
|
|
IMOS
559
ChipMOS TECHNOLOGIES
IMOS
$2.01B
| $28.1M | 0.04% |
1,310,100
-53,400
| -4% | -$1.1M |
|
560
HF Sinclair
DINO
$16.3B
| $28.1M | 0.04% |
540,682
+271,200
| +101% | +$15.6M |
|
561
WEC Energy
WEC
$35.9B
| $28M | 0.04% |
298,702
-322,575
| -52% | -$29.8M |
|
562
C.H. Robinson
CHRW
$17.5B
| $27.9M | 0.04% |
305,008
-200,400
| -40% | -$19.1M |
|
563
ConocoPhillips
COP
$150B
| $27.9M | 0.04% |
+236,325
| New | +$28.7M |
|
564
Transocean
RIG
$6.39B
| $27.8M | 0.04% |
6,092,063
-2,882,365
| -32% | -$11.1M |
|
565
National Healthcare
NHC
$3.44B
| $27.8M | 0.04% |
466,767
-36,220
| -7% | -$2.2M |
|
566
REX American Resources
REX
$1.44B
| $27.7M | 0.04% |
1,739,894
-107,936
| -6% | -$1.63M |
|
567
Chegg
CHGG
$89.3M
| $27.7M | 0.04% |
1,096,100
-23,700
| -2% | -$602K |
|
568
Lufax Holding
LU
$1.31B
| $27.6M | 0.04% |
3,554,688
+2,374,444
| +201% | +$18.1M |
|
|
CSR
569
Centerspace
CSR
$939M
| $27.6M | 0.04% |
469,716
-17,600
| -4% | -$1.14M |
|
570
Oneok
OKE
$58.4B
| $27.5M | 0.04% |
419,147
+53,847
| +15% | +$3.31M |
|
|
HTO
571
H2O America
HTO
$2.65B
| $27.5M | 0.04% |
338,900
-10,500
| -3% | -$751K |
|
572
Jack Henry & Associates
JKHY
$11.1B
| $27.4M | 0.04% |
+156,119
| New | +$28.8M |
|
573
ArcBest
ARCB
$3.28B
| $27.4M | 0.04% |
390,939
+29,400
| +8% | +$2.27M |
|
574
Truist Financial
TFC
$64.7B
| $27.2M | 0.04% |
+631,917
| New | +$27.7M |
|
575
Steven Madden
SHOO
$3.46B
| $27.2M | 0.04% |
850,667
-374,300
| -31% | -$11.7M |
|
Similar funds
Jim Simons's Q4 2022 Portfolio in Review
As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
- Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Jim Simons opened 626 new positions and closed 524 in Q4 2022.
- Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.